我们能治愈狼吗?
Tessa L Clement1, Philip L Cohen1
1Section of Rheumatology, Lewis Katz School of Medicine at Temple University, 3322 North Broad Street, Suite 201, Philadelphia, PA 19410, USA.
Current opinion in immunology
|August 16, 2025
概括
化学抗原受体T细胞 (CAR-T) 疗法在治疗系统性红血狼方面表现有前途,提供潜在的长期缓解. 在T细胞和NK细胞疗法的进步可能为这种自身免疫性疾病提供新的,实用的治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 自免疫性疾病 自免疫性疾病
- 细胞疗法细胞疗法
背景情况:
- 系统性红斑狼 (SLE) 的发病因子越来越被理解,但目前的治疗方法仍然很大程度上是经验性的,并且往往不令人满意.
- 以前的向疗法,包括单克隆抗体和干细胞治疗,在治疗SLE方面取得了有限的成功.
- 耐火性SLE病例在针对B细胞的仿真抗原受体T细胞 (CAR-T) 治疗中看到了意想不到的希望.
研究的目的:
- 审查CAR-T细胞疗法的新兴潜力,以治疗系统性红斑狼.
- 讨论SLE治疗细胞疗法的最新进展对SLE管理的影响.
- 突出系统生物学和单细胞方法在发现SLE新治疗点方面的作用.
主要方法:
- 审查最近的临床发现和细胞治疗系统性红斑狼的研究.
- 分析CAR-T细胞治疗在耐火性疾病的小患者队列中的疗效.
- 探索系统生物学和单细胞技术,以了解SLE的病原性.
主要成果:
- 在小型患者系列中,CAR-T细胞疗法已经表现出意想不到的前景,导致明显的长期和完全缓解SLE.
- 在T细胞和自然杀手 (NK) 细胞疗法方面的进展表明,更容易获得的和实用的治疗方法在地平线上.
- 了解SLE机制的进展正在确定治疗干预的新途径.
结论:
- 卡尔-T细胞疗法在治疗耐火性系统性红血性狼方面取得了重大进展.
- 细胞免疫疗法的未来发展,包括基于T细胞和NK细胞的策略,对SLE患者有很大的潜力.
- 通过系统生物学和单细胞分析,对SLE病变的持续研究可能会产生新的治疗选择,可能导致长期的疾病控制或治愈.
相关概念视频
01:29Autoimmune Disorders
672
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
672
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
01:21EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
01:20COPD: Pathogenesis and Clinical Features
521
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
521
01:26COPD: Management Using Bronchodilators and Corticosteroids
310
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
310
01:19Antiasthma Drugs: Leukotriene Modifiers
470
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
470